<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1360342</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Oxidative phosphorylation in HIV-1 infection: impacts on cellular metabolism and immune function</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rodriguez</surname>
<given-names>Natalia Rodriguez</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fortune</surname>
<given-names>Trinisia</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hegde</surname>
<given-names>Esha</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weinstein</surname>
<given-names>Matthew Paltiel</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keane</surname>
<given-names>Aislinn M.</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mangold</surname>
<given-names>Jesse F.</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2636321"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Swartz</surname>
<given-names>Talia H.</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/205920"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Pedro Gonzalez-Menendez, University of Oviedo, Spain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Nabab Khan, Yale University, United States</p>
<p>Charles Nathan S. Allen, University of Maryland, College Park, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Talia H. Swartz, <email xlink:href="mailto:talia.swartz@mssm.edu">talia.swartz@mssm.edu</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1360342</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Rodriguez, Fortune, Hegde, Weinstein, Keane, Mangold and Swartz</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Rodriguez, Fortune, Hegde, Weinstein, Keane, Mangold and Swartz</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Human Immunodeficiency Virus Type 1 (HIV-1) presents significant challenges to the immune system, predominantly characterized by CD4<sup>+</sup> T cell depletion, leading to Acquired Immunodeficiency Syndrome (AIDS). Antiretroviral therapy (ART) effectively suppresses the viral load in people with HIV (PWH), leading to a state of chronic infection that is associated with inflammation. This review explores the complex relationship between oxidative phosphorylation, a crucial metabolic pathway for cellular energy production, and HIV-1, emphasizing the dual impact of HIV-1 infection and the metabolic and mitochondrial effects of ART. The review highlights how HIV-1 infection disrupts oxidative phosphorylation, promoting glycolysis and fatty acid synthesis to facilitate viral replication. ART can exacerbate metabolic dysregulation despite controlling viral replication, impacting mitochondrial DNA synthesis and enhancing reactive oxygen species production. These effects collectively contribute to significant changes in oxidative phosphorylation, influencing immune cell metabolism and function. Adenosine triphosphate (ATP) generated through oxidative phosphorylation can influence the metabolic landscape of infected cells through ATP-detected purinergic signaling and contributes to immunometabolic dysfunction. Future research should focus on identifying specific targets within this pathway and exploring the role of purinergic signaling in HIV-1 pathogenesis to enhance HIV-1 treatment modalities, addressing both viral infection and its metabolic consequences.</p>
</abstract>
<kwd-group>
<kwd>HIV-1</kwd>
<kwd>oxidative phosphorylation</kwd>
<kwd>antiretroviral therapy (ART)</kwd>
<kwd>mitochondrial dysfunction</kwd>
<kwd>immune metabolism</kwd>
</kwd-group>
<contract-num rid="cn001">DA052255, DA054526</contract-num>
<contract-sponsor id="cn001">National Institute on Drug Abuse<named-content content-type="fundref-id">10.13039/100000026</named-content>
</contract-sponsor>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="142"/>
<page-count count="9"/>
<word-count count="3123"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Inflammation</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Human Immunodeficiency Virus Type 1 (HIV-1) presents a chronic, intractable challenge, primarily characterized by extensive CD4<sup>+</sup> T cell depletion (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>). This pathology manifests in both lymphoid tissues and peripheral blood, culminating in profound immunodeficiency and progression to Acquired Immunodeficiency Syndrome (AIDS). Despite the efficacy of Antiretroviral Therapy (ART) in viral load suppression, HIV-1 infection is associated with chronic inflammation and, together with the direct effects of ART, is associated with metabolic dysregulation, enhanced inflammatory response, gene expression modulation, and biochemical pathway alterations (<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>We explore the confluence of oxidative phosphorylation and cellular metabolic transformations in the context of HIV-1 infection and ART in PWH. Key focus areas include the nuances of mitochondrial dysfunction, specifically alterations in oxidative phosphorylation and association with immune cell dysregulation. This underscores a potential nexus between mitochondrial functionality and immunological response. Additionally, we examine the long-term impacts of ART and the potential for more nuanced HIV-1 treatment modalities. This review aims to enrich the understanding of the intricate interplay between oxidative phosphorylation and HIV-1 pathogenesis, steering future research and therapeutic interventions in this critical domain.</p>
</sec>
<sec id="s2">
<title>Oxidative phosphorylation: an overview</title>
<p>Oxidative phosphorylation, a crucial biochemical process, involves the reduction of oxygen to generate ATP (<xref ref-type="bibr" rid="B10">10</xref>). Oxidative phosphorylation is the final stage of aerobic respiration, following glycolysis and the citric acid cycle. The efficiency of oxidative phosphorylation relies on successive oxidative/reductive reactions, notably the transfer of electrons by NADH and FADH2 to oxygen, the ultimate electron acceptor (<xref ref-type="bibr" rid="B11">11</xref>). The electron transport chain (ETC) facilitates this electron movement within mitochondria. In order of oxidative/reductive reactions, the complexes are I, II, coenzyme Q, III, cytochrome C, and IV. This process pumps protons across the mitochondrial intermembrane space, generating a proton electrochemical gradient that powers ATP synthase (complex V) (<xref ref-type="bibr" rid="B12">12</xref>). ATP synthase facilitates ATP biosynthesis with its rotating F0 and F1 components. The F1 component binds nucleotides at its catalytic sites, occupied by Mg-ADP and phosphate. Rotation, driven by F0 subunit reionization, alters F1 directionality, initiating ATP synthesis from ADP and phosphite (<xref ref-type="bibr" rid="B13">13</xref>). ATP generated through oxidative phosphorylation, the final and most efficient stage of aerobic respiration in the electron transport chain, serves as the primary energy source for cells, far surpassing the yields from glycolysis and the citric acid cycle.</p>
<p>The regulation of oxidative phosphorylation is complex and multifaceted. The mitochondrial membrane potential is at the center of the regulation, formed by the proton gradient and linked to both ATP and free radical production (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). The most basic regulation of oxidative phosphorylation is allosteric control by negative feedback of substrates or intermediaries. A high NADH/NAD+ ratio slows the Krebs cycle, ETC, and oxidative phosphorylation, as does a high ATP/ADP ratio, in which ATP binds directly and inhibits cytochrome c (Cyt-c) and cytochrome oxidase (complex IV) (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>Oxidative phosphorylation complexes and Cyt-c are targeted for phosphorylation by regulatory kinases, including protein kinase C, cAMP-dependent tyrosine kinases, and EGFR (<xref ref-type="bibr" rid="B17">17</xref>&#x2013;<xref ref-type="bibr" rid="B19">19</xref>). The formation of super-complexes (SCs) or respirasomes, consisting of various combinations of the ETC complexes, increases respiratory efficiency and decreases ROS production. SC abundance, along with expression of specific isoforms of Cyt-c or cytochrome oxidase, allow for regulation of ROS formation and energetic needs at tissue-level specificity (<xref ref-type="bibr" rid="B15">15</xref>). The fusion and fission of the mitochondrial network contribute to oxidative phosphorylation efficiency regulation, with highly connected networks promoting efficiency and curbing excess ROS production (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>).</p>
</sec>
<sec id="s3">
<title>HIV-1 infection, metabolic preprogramming, cellular metabolism, and oxidative phosphorylation</title>
<p>Metabolic reprogramming is key in both cancer and HIV-1 infections. In cancer, this is seen as the Warburg effect, characterized by increased glucose uptake and lactate production, even when oxygen is available (<xref ref-type="bibr" rid="B22">22</xref>). Similarly, HIV-1 uses metabolic reprogramming to gather free nucleotides, amino acids, and lipids for viral replication and assembly (<xref ref-type="bibr" rid="B23">23</xref>). Studies reveal that CD4+ T cells with higher oxidative phosphorylation and glycolysis are more prone to HIV-1 infection, with infected cells showing elevated metabolic activity (<xref ref-type="bibr" rid="B24">24</xref>). HIV-1 also boosts glycolysis in CD4+ T cells by upregulating GLUT1 expression. The HIV-1 glycoprotein gp120 is implicated in this process, possibly by activating surface signaling molecules like CXCR4 and CCR5 and increasing the expression of glycolytic enzymes (<xref ref-type="bibr" rid="B25">25</xref>). Additionally, hexokinase activity is heightened in HIV-1 infected CD4+ T cells, a change dependent on viral replication (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). However, the precise viral mechanisms promoting glycolysis upregulation by HIV-1 are not fully understood.</p>
<p>There is growing interest in understanding the impact of HIV on Mitochondrial-associated ER membranes (MAMs) due to their crucial role in metabolic reprogramming. MAMs serve as structures linking the endoplasmic reticulum (ER) and mitochondria, facilitating oxidative protein production and mitochondrial biogenesis. The viral HIV-1 Tat protein disrupts MAMs in neuronal cell lines upon infection by phosphorylating the mitochondrial protein PTPIP51 and disrupting its localization to MAMs, thus reducing calcium signaling and increasing ROS accumulation (<xref ref-type="bibr" rid="B28">28</xref>). Furthermore, HIV-1 Vpr has been shown to disrupt MAMs by decreasing the expression of critical MAM-associated proteins Mfn2 and Drp1 (<xref ref-type="bibr" rid="B29">29</xref>). The targeting of MAMs by HIV-1 induces oxidative stress that contributes to HIV-associated metabolic reprogramming, but further research is needed to establish other key mechanisms involved.</p>
<p>HIV-1 impacts host cell metabolism, initially enhancing glycolysis and fatty acid synthesis for viral replication (<xref ref-type="bibr" rid="B30">30</xref>&#x2013;<xref ref-type="bibr" rid="B33">33</xref>). This increased metabolic activity, particularly in glycolysis and glucose transport, makes cells like T-cells and monocytes more susceptible to HIV-1 infection (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). Upregulation of the GLUT-1 transporter and mitochondrial oxidative damage, linked to ROS production, highlights the role of metabolic reprogramming in HIV-1 infection and potential research avenues (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). People with HIV (PWH) face systemic metabolic challenges due to both HIV-1 and antiretroviral therapy (ART), increasing metabolic disease risks (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). Studies have shown that HIV-1 influences metabolic aging, with oxidative phosphorylation and pyruvate metabolism downregulation noted in PWH (<xref ref-type="bibr" rid="B39">39</xref>). Furthermore, HIV-1 affects the expression of electron transport chain (ETC) components and causes mitochondrial damage, as seen in the upregulation of Complex-IV subunit, contributing to oxidative stress (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>).</p>
<p>ART classes have long been associated with mitochondria dysfunction (<xref ref-type="bibr" rid="B42">42</xref>). Both Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) and Non-nucleotide Reverse Transcriptase Inhibitors (NNRTIs) are associated with dyslipidemia in PWH and alter adipocyte differentiation. NRTIs induce lipodystrophy by promoting mitochondrial dysfunction and adipocyte death and interfering with mitochondrial DNA (mtDNA) synthesis (<xref ref-type="bibr" rid="B42">42</xref>). This inhibits Pol-gamma, increases ROS production, and reduces ETC activity and oxidative phosphorylation (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B42">42</xref>&#x2013;<xref ref-type="bibr" rid="B46">46</xref>). Additionally, protease inhibitors (PIs) target GLUT4, impairing glucose uptake into adipocytes and promoting insulin resistance (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>HIV-1 infection exacerbates oxidative stress and mitochondrial damage, affecting cell metabolism and promoting diseases in PWH, especially those on ART. Gp120 upregulates CYP2E1, proline oxidase (POX), NOX2, and NOX4 to enhance ROS production (<xref ref-type="bibr" rid="B49">49</xref>&#x2013;<xref ref-type="bibr" rid="B57">57</xref>). Nef interacts with the NADPH oxidases without affecting the NOX expression (<xref ref-type="bibr" rid="B57">57</xref>). The HIV-1 proteins Vpr and Tat both contribute to mitochondrial dysfunction: Vpr reduces membrane potential and triggers apoptosis by binding to ANT, part of the mitochondrial permeability transition pore, while Tat elevates free calcium levels in the cytoplasm by interacting with NADPH oxidases, leading to increased mitochondrial calcium uptake and reactive oxygen species (ROS) production (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B58">58</xref>&#x2013;<xref ref-type="bibr" rid="B64">64</xref>). These changes increase the risk of metabolic diseases in PWH, with ART compounds like NRTIs and PIs exacerbating (<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B66">66</xref>).</p>
</sec>
<sec id="s4">
<title>Purinergic receptors, ATP, and HIV pathogenesis</title>
<p>Purinergic receptors, particularly the P1 and P2 subtypes, are integral to inflammatory responses and the progression of HIV-1. The P2X receptors, activated by ATP, are crucial in initiating immune responses and impacting the HIV-1 viral life cycle (<xref ref-type="bibr" rid="B67">67</xref>&#x2013;<xref ref-type="bibr" rid="B71">71</xref>). The enzyme CD39 regulates ATP availability, influencing both the progression of AIDS and the function of T cells by modulating ATP and adenosine levels, affecting P2X receptor signaling (<xref ref-type="bibr" rid="B72">72</xref>&#x2013;<xref ref-type="bibr" rid="B74">74</xref>).</p>
<p>The P2X receptors are implicated in cell entry and infection by the virus, and their inhibition can significantly reduce HIV-1 infection in various cell types (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B75">75</xref>&#x2013;<xref ref-type="bibr" rid="B85">85</xref>). Chronic inflammation in HIV is driven by factors like immunosenescence and persistent viral replication, even with antiretroviral therapy (ART). It is exacerbated by factors such as organ fibrosis and co-infections (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B86">86</xref>&#x2013;<xref ref-type="bibr" rid="B88">88</xref>).</p>
<p>Furthermore, extracellular ATP and its interaction with P2X receptors regulate HIV infection and inflammation. This signaling leads to the production of inflammatory cytokines and the activation of the NLRP3 inflammasome, contributing to CD4+ T lymphocyte depletion and apoptosis (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B89">89</xref>&#x2013;<xref ref-type="bibr" rid="B92">92</xref>). HIV-1 interacts with Pannexin-1, a membrane channel, suggesting a link between ATP production and inflammatory signaling in HIV-1 infection (<xref ref-type="bibr" rid="B93">93</xref>&#x2013;<xref ref-type="bibr" rid="B96">96</xref>). Circulating levels of ATP have been proposed as a biomarker of cognitive decline in PWH, predicting central nervous system compromise and suggesting the use of Pannexin-1 or purinergic receptor inhibitors for clinical intervention (<xref ref-type="bibr" rid="B97">97</xref>).</p>
</sec>
<sec id="s5">
<title>HIV-associated neurocognitive disorder: the roles of HIV-1, ART, oxidative phosphorylation, and purinergic signaling</title>
<p>The progression of HIV-1-associated neurocognitive disorders (HAND) in PWH has been linked to purinergic signaling and oxidative stress. The central nervous system serves as a reservoir of HIV-1, leading to neuroinflammation and neurodegeneration that progress to HIV-1 encephalitis and HAND that persist despite the use of effective ART (<xref ref-type="bibr" rid="B98">98</xref>&#x2013;<xref ref-type="bibr" rid="B100">100</xref>). Within the CNS, HIV-1 induces the release of extracellular ATP in infected cells to support viral replication, and ATP interacts with purinergic receptors to produce a proinflammatory response (<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B101">101</xref>, <xref ref-type="bibr" rid="B102">102</xref>). The purinergic receptor subtype P2X is particularly interesting, notably P2X7, which is widely expressed in various brain cells, including astrocytes, oligodendrocytes, microglia, and neurons (<xref ref-type="bibr" rid="B102">102</xref>). In astrocytes, P2X7 activation induced by gp120 leads to Cx43 hemichannels and pannexin-1 opening, resulting in increased ATP release and nitric oxide production. This process is speculated to propagate gp120-mediated signaling to neighboring cells (<xref ref-type="bibr" rid="B95">95</xref>). In the peripheral nervous system (PNS), P2X4 is involved in gp120-induced lysosomal exocytosis and ATP release in Schwann Cells, increasing cytosolic calcium and generating ROS in dorsal root ganglia neurons (<xref ref-type="bibr" rid="B101">101</xref>). Although ART mitigates the neuropathology of HIV-1 infection in PWH, it does not eliminate it, with studies showing possible neurotoxicity of ART. ART-related neurotoxicity in the brain is thought to be linked to the loss of mtDNA due to NRTIs inhibiting mtDNA polymerase gamma (<xref ref-type="bibr" rid="B103">103</xref>, <xref ref-type="bibr" rid="B104">104</xref>). Additionally, ART contributes to astrocyte autophagy, de-acidification of endolysosomes, and the promotion of amyloidogenesis, all associated with the pathogenesis of HAND (<xref ref-type="bibr" rid="B105">105</xref>).</p>
<p>Extracellular ATP and P2X receptors are integral in HIV-1 infection, influencing the virus&#x2019;s life cycle and contributing to immunopathogenesis, neurodegeneration, and chronic inflammation. Their interaction with HIV-1 is key in disease progression, affecting viral replication, cytokine release, and cell death (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B83">83</xref>&#x2013;<xref ref-type="bibr" rid="B85">85</xref>). This insight reveals the potential of targeting purinergic signaling in developing novel therapies for HIV-1, reducing inflammation and related comorbidities, and represents a significant area for future research.</p>
</sec>
<sec id="s6">
<title>Oxidative phosphorylation in immune cell dysfunction during HIV-1 infection</title>
<p>The metabolic dynamics of immune cells, particularly CD4+ T cells, CD8+ T cells, and macrophages, are critical in understanding HIV-1 pathophysiology. CD4+ T cells infected with HIV-1 shift towards increased glycolysis, facilitating viral replication. A study identified a link between oxidative phosphorylation in these cells and higher viral loads, with NLRX1 and FASTKD5 as key factors. Metformin, a complex I inhibitor, was found to suppress HIV-1 replication in CD4+ T cells (<xref ref-type="bibr" rid="B106">106</xref>). In PWH on ART, there&#x2019;s an upregulation of oxidative phosphorylation compared to elite controllers, and complex IV inhibition was linked to increased HIV-1 reactivation in a latency model (<xref ref-type="bibr" rid="B107">107</xref>).</p>
<p>CD8+ T cells in chronic HIV-1 infection experience metabolic exhaustion, diminishing their functionality and virus control ability. A combination therapy comprised of a mitochondrial superoxide scavenger, a small-molecule inhibitor of mitochondrial fission, and IL-15 can increase the frequency of IFNy and TNFa poly-functional CD8+ T cells and decrease the frequency of exhaustion markers (<xref ref-type="bibr" rid="B108">108</xref>).</p>
<p>In HIV-infected macrophages, there is notable support for prolonged HIV-1 replication and survival, shielding virions from ART and neutralizing antibodies. These macrophages show metabolic plasticity, shifting between oxidative phosphorylation and glycolysis based on their polarization state. HIV-1 infection alters macrophage metabolism, promoting a pro-inflammatory state and increasing glycolytic activity, which is linked to chronic inflammation seen in HIV-1 infection (<xref ref-type="bibr" rid="B109">109</xref>). A study demonstrated that superoxide dismutase (SOD) mimetic drugs could inhibit myeloid cell-driven bystander cell death <italic>in vitro</italic> (<xref ref-type="bibr" rid="B110">110</xref>).</p>
<p>
<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref> highlights the impact of HIV-1 infection on mitochondrial oxidative phosphorylation. It contrasts the normal mitochondrial function with the altered state during HIV-1 infection, depicting how HIV-1 infection leads to an upregulation in the transcription of oxidative phosphorylation genes, resulting in greater electron transport chain efficiency. This heightened activity leads to increased production of ROS, a hallmark of cellular stress. Consequently, there&#x2019;s an enhancement in mitochondrial membrane potential and a notable increase in ATP production compared to baseline conditions. These alterations signify a hyperactivated mitochondrial state triggered by HIV-1 infection, underlining the complex interplay between the virus and the host&#x2019;s cellular metabolism.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>HIV-1 Infection impact on mitochondrial oxidative phosphorylation. The figure contrasts mitochondrial function under normal conditions with the altered state during HIV-1 infection. It shows that HIV-1 infection leads to increased transcription of oxidative phosphorylation genes, higher electron transport efficiency, and elevated reactive oxygen species (ROS) production, resulting in an enhanced mitochondrial membrane potential and increased ATP production compared to the baseline state. These changes indicate a hyperactivated mitochondrial state in response to HIV-1 infection. Made with <uri xlink:href="https://www.biorender.com">biorender.com</uri>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1360342-g001.tif"/>
</fig>
</sec>
<sec id="s7">
<title>Current research and future directions</title>
<p>Therapeutic interventions targeting mitochondrial dysfunction and oxidative stress in HIV immunopathogenesis are emerging as a crucial field of research. Metformin, a diabetes medication, has shown varying effects on HIV-1 replication in studies by Rezai et&#xa0;al. and Guo et&#xa0;al. (<xref ref-type="bibr" rid="B106">106</xref>, <xref ref-type="bibr" rid="B111">111</xref>). There is an additive effect of risk of metformin-associated lactic acidosis when used with NRTIs like tenofovir, which calls for caution in its clinical application (<xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B113">113</xref>). Research on the antioxidant properties of plant flavonoids, such as naringin, is gaining attention for their potential to mitigate oxidative damage induced by NRTIs (<xref ref-type="bibr" rid="B114">114</xref>, <xref ref-type="bibr" rid="B115">115</xref>). Statins, known for their anti-inflammatory and lipid-lowering effects, are being explored for their benefits in HIV management, with studies like SATURN-HIV and REPRIEVE indicating their impact on cardiovascular risk and mitochondrial function in PWH on ART (<xref ref-type="bibr" rid="B116">116</xref>&#x2013;<xref ref-type="bibr" rid="B118">118</xref>).</p>
<p>Given that HIV-1 infection induces metabolic reprogramming like that observed in cancer cells, there is growing interest in exploring anti-cancer drug treatments as potential interventions to target these metabolic effects of HIV-1 (<xref ref-type="bibr" rid="B119">119</xref>). In neurons, the viral protein gp120 reduces ATP output via oxidative phosphorylation while increasing glycolysis production and PKM2 expression. Tepp-46, a selective PKM2 tetrameric stabilizer and a potential small molecule therapeutics for lung cancer, has demonstrated the ability to reverse the metabolic reprogramming induced by gp120 in neuronal cells (<xref ref-type="bibr" rid="B120">120</xref>). Further, studies have linked dyslipidemia in PWH on ART with mitochondrial oxidative stress, suggesting an association between lipid profiles and the function of mitochondrial electron transport chain complexes (<xref ref-type="bibr" rid="B121">121</xref>). Atovaquone, a mitochondrial complex III inhibitor, though not tested in chronic inflammation, is used for treating parasitic and fungal infections (<xref ref-type="bibr" rid="B81">81</xref>).</p>
<p>Advancements in understanding HIV-1 pathogenesis highlight the role of purinergic signaling, particularly the involvement of extracellular ATP and P2X receptors. These receptors play a significant role in the inflammatory response and immune modulation in HIV-1 infection (<xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B113">113</xref>). This growing body of research underlines the importance of understanding the metabolic and mitochondrial aspects of HIV-1 infection and ART. The goal is to improve treatment outcomes by mitigating adverse effects and exploring new therapeutic avenues that address both HIV-1 management and broader metabolic and cardiovascular health.</p>
</sec>
<sec id="s8" sec-type="conclusions">
<title>Conclusions</title>
<p>The interaction between HIV-1 infection and metabolic activity significantly shapes the chronic inflammation commonly associated with HIV. The activation of oxidative phosphorylation is a key driver in chronic inflammation. This shift is evident in studies documenting the increased activity of mitochondrial respiratory chain complexes in HIV-1 infected cells (<xref ref-type="bibr" rid="B122">122</xref>&#x2013;<xref ref-type="bibr" rid="B132">132</xref>). Such changes suggest that HIV-1 exploits the host&#x2019;s mitochondrial machinery to its advantage, potentially exacerbating the inflammatory response. While ART effectively controls viral replication, it does not fully rectify this metabolic dysregulation, adding another layer to the complexity. Long-term ART use has been associated with continued mitochondrial dysfunction (<xref ref-type="bibr" rid="B133">133</xref>, <xref ref-type="bibr" rid="B134">134</xref>), indicating that the impact of HIV on oxidative phosphorylation is a persistent challenge.</p>
<p>HIV-1 infection significantly disrupts host cell metabolism, increasing glycolysis and fatty acid synthesis to enhance viral replication, leading to oxidative stress and mitochondrial damage. This is further complicated by antiretroviral therapy (ART), which contributes to metabolic conditions like dyslipidemia and insulin resistance, intensifying mitochondrial dysfunction (<xref ref-type="bibr" rid="B135">135</xref>&#x2013;<xref ref-type="bibr" rid="B137">137</xref>).</p>
<p>Studies show that both HIV-1 infection and prolonged ART use increase the risk of oxidative phosphorylation dysregulation and mitochondrial disruption in people with HIV (PWH) (<xref ref-type="bibr" rid="B122">122</xref>&#x2013;<xref ref-type="bibr" rid="B132">132</xref>). Reduced activity of respiratory chain complexes and altered mitochondrial functioning in ART-na&#xef;ve PWH have been linked to neurocognitive impairment (<xref ref-type="bibr" rid="B125">125</xref>). ART&#x2019;s impact on oxidative phosphorylation in PWH also suggests a reduction in mitochondrial function associated with chronic/controlled HIV-1 (<xref ref-type="bibr" rid="B133">133</xref>). Interestingly, pre-exposure prophylaxis (PreP) also shows reduced mitochondrial function in healthy individuals (<xref ref-type="bibr" rid="B134">134</xref>). Gender-specific differences in response to long-term ART have been observed, indicating possible variations in immunological recovery (<xref ref-type="bibr" rid="B138">138</xref>).</p>
<p>Recent studies highlight the role of purinergic signaling, particularly the interaction between extracellular ATP and P2X receptors, in HIV-1 pathogenesis (<xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B113">113</xref>). These receptors, activated by ATP released from stressed cells, influence the HIV-1 life cycle and contribute to immunometabolic dysfunction (<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B106">106</xref>, <xref ref-type="bibr" rid="B109">109</xref>). The dual role of these receptors in potentially inhibiting or facilitating HIV replication is mediated through CD39, which modulates extracellular ATP levels (<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B139">139</xref>&#x2013;<xref ref-type="bibr" rid="B142">142</xref>).</p>
<p>Understanding the interplay between HIV-1 infection, ART, oxidative phosphorylation, and purinergic signaling is crucial for developing comprehensive HIV-1 treatment strategies. This involves addressing the viral challenges and the broader metabolic and mitochondrial dysfunctions. Future research should focus on identifying specific targets influenced by HIV-1 and ART and exploring the impact of purinergic signaling on these pathways. Such targeted exploration may lead to innovative therapeutic approaches addressing the infection and its metabolic and mitochondrial consequences.</p>
</sec>
<sec id="s9" sec-type="author-contributions">
<title>Author contributions</title>
<p>NR: Conceptualization, Data curation, Investigation, Methodology, Project administration, Software, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. TF: Writing &#x2013; original draft. EH: Writing &#x2013; original draft. MW: Writing &#x2013; original draft. AK: Writing &#x2013; original draft. JM: Writing &#x2013; original draft. TS: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s10" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work is supported by T32GM146636 (JM), NIDA R01 DA052255 (TS), NIDA R01 DA054526 (TS), NIMH R01 MH134319 (TS), and NIAID R21 AI162223 (TS). </p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We are especially grateful to our colleagues at the Icahn School of Medicine at Mount Sinai Chen/Swartz laboratory for their continuous support and constructive criticism during the writing and editing process. Their expertise and perspectives have been instrumental in refining the content and focus of this review. Our heartfelt thanks to all the patients and volunteers who have participated in HIV research. Their involvement has been fundamental in advancing our understanding of the disease and developing effective treatment strategies.</p>
</ack>
<sec id="s11" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>HIV-1, Human Immunodeficiency Virus Type 1; ART, Antiretroviral Therapy; PBMC, Peripheral Blood Mononuclear Cells; ROS, Reactive Oxygen Species; ETC, Electron Transport Chain; NRTIs, Nucleoside/Nucleotide Reverse Transcriptase Inhibitors; NNRTIs, Non-nucleoside Reverse Transcriptase Inhibitors; PIs, Protease Inhibitors; ATP, Adenosine Triphosphate; NADH, Nicotinamide Adenine Dinucleotide (Reduced Form); FADH2, Flavin Adenine Dinucleotide (Reduced Form); Cyt-c, Cytochrome c; TCA, Tricarboxylic Acid Cycle; GLUT1, Glucose Transporter 1; SMO, Spermine Oxidase; EGFR, Epidermal Growth Factor Receptor; mTFA, Mitochondrial Transcription Factor A.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellis</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Iudicello</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Heaton</surname> <given-names>RK</given-names>
</name>
<name>
<surname>Isnard</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Routy</surname> <given-names>JP</given-names>
</name>
<etal/>
</person-group>. <article-title>Markers of gut barrier function and microbial translocation associate with lower gut microbial diversity in people with HIV</article-title>. <source>Viruses</source>. (<year>2021</year>) <volume>13</volume>(<issue>1</issue>)<fpage>:1891</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/v13101891</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mu&#xf1;oz-Arias</surname> <given-names>I</given-names>
</name>
<name>
<surname>Doitsh</surname> <given-names>G</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Sowinski</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ruelas</surname> <given-names>D</given-names>
</name>
<name>
<surname>Greene</surname> <given-names>WC</given-names>
</name>
</person-group>. <article-title>Blood-derived CD4 T cells naturally resist pyroptosis during abortive HIV-1 infection</article-title>. <source>Cell Host Microbe</source>. (<year>2015</year>) <volume>18</volume>:<page-range>463&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2015.09.010</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okoye</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Picker</surname> <given-names>LJ</given-names>
</name>
</person-group>. <article-title>CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure</article-title>. <source>Immunol Rev</source>. (<year>2013</year>) <volume>254</volume>:<fpage>54</fpage>&#x2013;<lpage>64</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imr.12066</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lederman</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Calabrese</surname> <given-names>L</given-names>
</name>
<name>
<surname>Funderburg</surname> <given-names>NT</given-names>
</name>
<name>
<surname>Clagett</surname> <given-names>B</given-names>
</name>
<name>
<surname>Medvik</surname> <given-names>K</given-names>
</name>
<name>
<surname>Bonilla</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells</article-title>. <source>J Infect Dis</source>. (<year>2011</year>) <volume>204</volume>:<page-range>1217&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jir507</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bandera</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ferrario</surname> <given-names>G</given-names>
</name>
<name>
<surname>Saresella</surname> <given-names>M</given-names>
</name>
<name>
<surname>Marventano</surname> <given-names>I</given-names>
</name>
<name>
<surname>Soria</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zanini</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals</article-title>. <source>PloS One</source>. (<year>2010</year>) <volume>5</volume>:<fpage>e10788</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0010788</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tenorio</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bosch</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Krishnan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Rodriguez</surname> <given-names>B</given-names>
</name>
<name>
<surname>Hunt</surname> <given-names>PW</given-names>
</name>
<etal/>
</person-group>. <article-title>Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment</article-title>. <source>J Infect Dis</source>. (<year>2014</year>) <volume>210</volume>:<page-range>1248&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jiu254</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deeks</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Tracy</surname> <given-names>R</given-names>
</name>
<name>
<surname>Douek</surname> <given-names>DC</given-names>
</name>
</person-group>. <article-title>Systemic effects of inflammation on health during chronic HIV infection</article-title>. <source>Immunity</source>. (<year>2013</year>) <volume>39</volume>:<page-range>633&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2013.10.001</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klatt</surname> <given-names>NR</given-names>
</name>
<name>
<surname>Chomont</surname> <given-names>N</given-names>
</name>
<name>
<surname>Douek</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Deeks</surname> <given-names>SG</given-names>
</name>
</person-group>. <article-title>Immune activation and HIV persistence: implications for curative approaches to HIV infection</article-title>. <source>Immunol Rev</source>. (<year>2013</year>) <volume>254</volume>:<page-range>326&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imr.12065</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deeks</surname> <given-names>SG</given-names>
</name>
</person-group>. <article-title>HIV infection, inflammation, immunosenescence, and aging</article-title>. <source>Annu Rev Med</source>. (<year>2011</year>) <volume>62</volume>:<page-range>141&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-med-042909-093756</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname> <given-names>DF</given-names>
</name>
</person-group>. <article-title>Oxidative phosphorylation: regulation and role in cellular and tissue metabolism</article-title>. <source>J Physiol</source>. (<year>2017</year>) <volume>595</volume>:<page-range>7023&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1113/JP273839</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miranda-Quintana</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Mart&#xed;nez Gonz&#xe1;lez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ayers</surname> <given-names>PW</given-names>
</name>
</person-group>. <article-title>Electronegativity and redox reactions</article-title>. <source>Phys Chem Chem Phys</source>. (<year>2016</year>) <volume>18</volume>:<page-range>22235&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/C6CP03213C</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matlin</surname> <given-names>KS</given-names>
</name>
</person-group>. <article-title>The heuristic of form: mitochondrial morphology and the explanation of oxidative phosphorylation</article-title>. <source>J Hist Biol</source>. (<year>2016</year>) <volume>49</volume>:<fpage>37</fpage>&#x2013;<lpage>94</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10739-015-9418-3</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nirody</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Budin</surname> <given-names>I</given-names>
</name>
<name>
<surname>Rangamani</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>ATP synthase: Evolution, energetics, and membrane interactions</article-title>. <source>J Gen Physiol</source>. (<year>2020</year>) <volume>152</volume>(<issue>11</issue>)<fpage>:e201912475</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1085/jgp.201912475</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hroudov&#xe1;</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fi&#x161;ar</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Control mechanisms in mitochondrial oxidative phosphorylation</article-title>. <source>Neural Regener Res</source>. (<year>2013</year>) <volume>8</volume>:<page-range>363&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3969/j.issn.1673-5374.2013.04.009</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xfc;ttemann</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>I</given-names>
</name>
<name>
<surname>Pecinova</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pecina</surname> <given-names>P</given-names>
</name>
<name>
<surname>Przyklenk</surname> <given-names>K</given-names>
</name>
<name>
<surname>Doan</surname> <given-names>JW</given-names>
</name>
</person-group>. <article-title>Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease</article-title>. <source>J Bioenerg Biomembr</source>. (<year>2008</year>) <volume>40</volume>:<page-range>445&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10863-008-9169-3</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferguson-Miller</surname> <given-names>S</given-names>
</name>
<name>
<surname>Brautigan</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Margoliash</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Correlation of the kinetics of electron transfer activity of various eukaryotic cytochromes c with binding to mitochondrial cytochrome c oxidase</article-title>. <source>J Biol Chem</source>. (<year>1976</year>) <volume>251</volume>:<page-range>1104&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0021-9258(17)33807-3</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ogbi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tawfik</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>G</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. (<year>2007</year>) <volume>293</volume>:<page-range>H2219&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpheart.01306.2006</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boerner</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Demory</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>C</given-names>
</name>
<name>
<surname>Parsons</surname> <given-names>SJ</given-names>
</name>
</person-group>. <article-title>Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II</article-title>. <source>Mol Cell Biol</source>. (<year>2004</year>) <volume>24</volume>:<page-range>7059&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MCB.24.16.7059-7071.2004</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>I</given-names>
</name>
<name>
<surname>Salomon</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Ficarro</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mathes</surname> <given-names>I</given-names>
</name>
<name>
<surname>Lottspeich</surname> <given-names>F</given-names>
</name>
<name>
<surname>Grossman</surname> <given-names>LI</given-names>
</name>
<etal/>
</person-group>. <article-title>cAMP-dependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity</article-title>. <source>J Biol Chem</source>. (<year>2005</year>) <volume>280</volume>:<page-range>6094&#x2013;100</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M411335200</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serasinghe</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Wieder</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Renault</surname> <given-names>TT</given-names>
</name>
<name>
<surname>Elkholi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Asciolla</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>JL</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors</article-title>. <source>Mol Cell</source>. (<year>2015</year>) <volume>57</volume>:<page-range>521&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2015.01.003</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Fabuel</surname> <given-names>I</given-names>
</name>
<name>
<surname>Le Douce</surname> <given-names>J</given-names>
</name>
<name>
<surname>Logan</surname> <given-names>A</given-names>
</name>
<name>
<surname>James</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Bonvento</surname> <given-names>G</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>MP</given-names>
</name>
<etal/>
</person-group>. <article-title>Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2016</year>) <volume>113</volume>:<page-range>13063&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1613701113</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaupel</surname> <given-names>P</given-names>
</name>
<name>
<surname>Schmidberger</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mayer</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression</article-title>. <source>Int J Radiat Biol</source>. (<year>2019</year>) <volume>95</volume>:<page-range>912&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/09553002.2019.1589653</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Lagunoff</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Viral activation of cellular metabolism</article-title>. <source>Virology</source>. (<year>2015</year>) <volume>479-480</volume>:<page-range>609&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.virol.2015.02.038</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valle-Casuso</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Angin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Volant</surname> <given-names>S</given-names>
</name>
<name>
<surname>Passaes</surname> <given-names>C</given-names>
</name>
<name>
<surname>Monceaux</surname> <given-names>V</given-names>
</name>
<name>
<surname>Mikhailova</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Cellular metabolism is a major determinant of HIV-1 reservoir seeding in CD4</article-title>. <source>Cell Metab</source>. (<year>2019</year>) <volume>29</volume>:<fpage>611</fpage>&#x2013;<lpage>626.e5</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2018.11.015</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valent&#xed;n-Guillama</surname> <given-names>G</given-names>
</name>
<name>
<surname>L&#xf3;pez</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kucheryavykh</surname> <given-names>YV</given-names>
</name>
<name>
<surname>Chorna</surname> <given-names>NE</given-names>
</name>
<name>
<surname>P&#xe9;rez</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ortiz-Rivera</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>HIV-1 envelope protein gp120 promotes proliferation and the activation of glycolysis in glioma cell</article-title>. <source>Cancers (Basel)</source>. (<year>2018</year>) <volume>10</volume>(<issue>9</issue>)<fpage>:301</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers10090301</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kavanagh Williamson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Coombes</surname> <given-names>N</given-names>
</name>
<name>
<surname>Juszczak</surname> <given-names>F</given-names>
</name>
<name>
<surname>Athanasopoulos</surname> <given-names>M</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Eykyn</surname> <given-names>TR</given-names>
</name>
<etal/>
</person-group>. <article-title>Upregulation of glucose uptake and hexokinase activity of primary human CD4+ T cells in response to infection with HIV-1</article-title>. <source>Viruses</source>. (<year>2018</year>) <volume>10</volume>(<issue>3</issue>)<fpage>:114</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/v10030114</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hegedus</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kavanagh Williamson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Huthoff</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>HIV-1 pathogenicity and virion production are dependent on the metabolic phenotype of activated CD4+ T cells</article-title>. <source>Retrovirology</source>. (<year>2014</year>) <volume>11</volume>:<fpage>98</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12977-014-0098-4</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arjona</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>CNS</given-names>
</name>
<name>
<surname>Santerre</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gross</surname> <given-names>S</given-names>
</name>
<name>
<surname>Soboloff</surname> <given-names>J</given-names>
</name>
<name>
<surname>Booze</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Disruption of Mitochondrial-associated ER membranes by HIV-1 tat protein contributes to premature brain aging</article-title>. <source>CNS Neurosci Ther</source>. (<year>2023</year>) <volume>29</volume>:<page-range>365&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cns.14011</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Chiang</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>TY</given-names>
</name>
<name>
<surname>Chiou</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Chow</surname> <given-names>KC</given-names>
</name>
</person-group>. <article-title>HIV-1 Vpr triggers mitochondrial destruction by impairing Mfn2-mediated ER-mitochondria interaction</article-title>. <source>PloS One</source>. (<year>2012</year>) <volume>7</volume>:<fpage>e33657</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0033657</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crater</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Nixon</surname> <given-names>DF</given-names>
</name>
<name>
<surname>Furler O&#x2019;Brien</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>HIV-1 replication and latency are balanced by mTOR-driven cell metabolism</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2022</year>) <volume>12</volume>:<elocation-id>1068436</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.1068436</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollenbaugh</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Munger</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis</article-title>. <source>Virology</source>. (<year>2011</year>) <volume>415</volume>:<page-range>153&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.virol.2011.04.007</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahouassa</surname> <given-names>H</given-names>
</name>
<name>
<surname>Daddacha</surname> <given-names>W</given-names>
</name>
<name>
<surname>Hofmann</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ayinde</surname> <given-names>D</given-names>
</name>
<name>
<surname>Logue</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Dragin</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates</article-title>. <source>Nat Immunol</source>. (<year>2012</year>) <volume>13</volume>:<page-range>223&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.2236</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ono</surname> <given-names>A</given-names>
</name>
<name>
<surname>Waheed</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Freed</surname> <given-names>EO</given-names>
</name>
</person-group>. <article-title>Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag</article-title>. <source>Virology</source>. (<year>2007</year>) <volume>360</volume>:<fpage>27</fpage>&#x2013;<lpage>35</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.virol.2006.10.011</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahman</surname> <given-names>AN</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Mujib</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kidane</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>A</given-names>
</name>
<name>
<surname>Szep</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated glycolysis imparts functional ability to CD8</article-title>. <source>Life Sci Alliance</source>. (<year>2021</year>) <volume>4</volume>(<issue>11</issue>)<fpage>:e202101081</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.26508/lsa.202101081</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmer</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Cherry</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Sada-Ovalle</surname> <given-names>I</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>A</given-names>
</name>
<name>
<surname>Crowe</surname> <given-names>SM</given-names>
</name>
</person-group>. <article-title>Glucose metabolism in T cells and monocytes: new perspectives in HIV pathogenesis</article-title>. <source>EBioMedicine</source>. (<year>2016</year>) <volume>6</volume>:<fpage>31</fpage>&#x2013;<lpage>41</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ebiom.2016.02.012</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loisel-Meyer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Swainson</surname> <given-names>L</given-names>
</name>
<name>
<surname>Craveiro</surname> <given-names>M</given-names>
</name>
<name>
<surname>Oburoglu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Mongellaz</surname> <given-names>C</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Glut1-mediated glucose transport regulates HIV infection</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2012</year>) <volume>109</volume>:<page-range>2549&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1121427109</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname> <given-names>D</given-names>
</name>
<name>
<surname>Roy</surname> <given-names>D</given-names>
</name>
<name>
<surname>Cassol</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Examining relationships between metabolism and persistent inflammation in HIV patients on antiretroviral therapy</article-title>. <source>Mediators Inflammation</source>. (<year>2018</year>) <volume>2018</volume>:<fpage>6238978</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2018/6238978</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wester</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Okezie</surname> <given-names>OA</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Bussmann</surname> <given-names>H</given-names>
</name>
<name>
<surname>Moyo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Muzenda</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial</article-title>. <source>J Acquir Immune Defic Syndr</source>. (<year>2007</year>) <volume>46</volume>:<page-range>318&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/QAI.0b013e3181568e3f</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikaeloff</surname> <given-names>F</given-names>
</name>
<name>
<surname>Gelpi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Escos</surname> <given-names>A</given-names>
</name>
<name>
<surname>Knudsen</surname> <given-names>AD</given-names>
</name>
<name>
<surname>H&#xf8;gh</surname> <given-names>J</given-names>
</name>
<name>
<surname>Benfield</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Transcriptomics age acceleration in prolonged treated HIV infection</article-title>. <source>Aging Cell</source>. (<year>2023</year>) <volume>22</volume>:<fpage>e13951</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/acel.13951</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tripathy</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Mitra</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Differential modulation of mitochondrial OXPHOS system during HIV-1 induced T-cell apoptosis: up regulation of Complex-IV subunit COX-II and its possible implications</article-title>. <source>Apoptosis</source>. (<year>2010</year>) <volume>15</volume>:<fpage>28</fpage>&#x2013;<lpage>40</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10495-009-0408-9</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kallianpur</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Walker</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gerschenson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Shikuma</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Gangcuangco</surname> <given-names>LMA</given-names>
</name>
<name>
<surname>Kohorn</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Systemic mitochondrial oxidative phosphorylation protein levels correlate with neuroimaging measures in chronically HIV-infected individuals</article-title>. <source>AIDS Res Hum Retroviruses</source>. (<year>2020</year>) <volume>36</volume>:<fpage>83</fpage>&#x2013;<lpage>91</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/aid.2019.0240</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maagaard</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kvale</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity</article-title>. <source>Scand J Infect Dis</source>. (<year>2009</year>) <volume>41</volume>:<page-range>808&#x2013;17</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/00365540903186181</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feeney</surname> <given-names>ER</given-names>
</name>
<name>
<surname>van Vonderen</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Wit</surname> <given-names>F</given-names>
</name>
<name>
<surname>Danner</surname> <given-names>SA</given-names>
</name>
<name>
<surname>van Agtmael</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Villarroya</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA</article-title>. <source>AIDS</source>. (<year>2012</year>) <volume>26</volume>:<page-range>2165&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/QAD.0b013e328358b279</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McComsey</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Daar</surname> <given-names>ES</given-names>
</name>
<name>
<surname>O&#x2019;Riordan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Collier</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Kosmiski</surname> <given-names>L</given-names>
</name>
<name>
<surname>Santana</surname> <given-names>JL</given-names>
</name>
<etal/>
</person-group>. <article-title>Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202</article-title>. <source>J Infect Dis</source>. (<year>2013</year>) <volume>207</volume>:<page-range>604&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jis720</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maagaard</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kvale</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms</article-title>? <source>J Antimicrob Chemother</source>. (<year>2009</year>) <volume>64</volume>:<page-range>901&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkp316</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname> <given-names>W</given-names>
</name>
<name>
<surname>Dalakas</surname> <given-names>MC</given-names>
</name>
</person-group>. <article-title>Mitochondrial toxicity of antiviral drugs</article-title>. <source>Nat Med</source>. (<year>1995</year>) <volume>1</volume>:<page-range>417&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm0595-417</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murata</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hruz</surname> <given-names>PW</given-names>
</name>
<name>
<surname>Mueckler</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations</article-title>. <source>AIDS</source>. (<year>2002</year>) <volume>16</volume>:<page-range>859&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00002030-200204120-00005</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murata</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hruz</surname> <given-names>PW</given-names>
</name>
<name>
<surname>Mueckler</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The mechanism of insulin resistance caused by HIV protease inhibitor therapy</article-title>. <source>J Biol Chem</source>. (<year>2000</year>) <volume>275</volume>:<page-range>20251&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.C000228200</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hileman</surname> <given-names>CO</given-names>
</name>
<name>
<surname>Kalayjian</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Azzam</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schlatzer</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tassiopoulos</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Plasma citrate and succinate are associated with neurocognitive impairment in older people with HIV</article-title>. <source>Clin Infect Dis</source>. (<year>2021</year>) <volume>73</volume>:<page-range>e765&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cid/ciab107</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hutter</surname> <given-names>E</given-names>
</name>
<name>
<surname>Gonchoroff</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Perl</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase</article-title>. <source>J Biol Chem</source>. (<year>1998</year>) <volume>273</volume>:<page-range>11944&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.273.19.11944</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deshmane</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Mukerjee</surname> <given-names>R</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Del Valle</surname> <given-names>L</given-names>
</name>
<name>
<surname>Michiels</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sweet</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression</article-title>. <source>J Biol Chem</source>. (<year>2009</year>) <volume>284</volume>:<page-range>11364&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M809266200</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>HIV gp120- and methamphetamine-mediated oxidative stress induces astrocyte apoptosis via cytochrome P450 2E1</article-title>. <source>Cell Death Dis</source>. (<year>2013</year>) <volume>4</volume>:<fpage>e850</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cddis.2013.374</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foga</surname> <given-names>IO</given-names>
</name>
<name>
<surname>Nath</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hasinoff</surname> <given-names>BB</given-names>
</name>
<name>
<surname>Geiger</surname> <given-names>JD</given-names>
</name>
</person-group>. <article-title>Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells</article-title>. <source>J Acquir Immune Defic Syndr Hum Retrovirol</source>. (<year>1997</year>) <volume>16</volume>:<page-range>223&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00042560-199712010-00001</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mataramvura</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bunders</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Duri</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Human immunodeficiency virus and antiretroviral therapy-mediated immune cell metabolic dysregulation in children born to HIV-infected women: potential clinical implications</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1182217</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1182217</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecoeur</surname> <given-names>H</given-names>
</name>
<name>
<surname>Borgne-Sanchez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chaloin</surname> <given-names>O</given-names>
</name>
<name>
<surname>El-Khoury</surname> <given-names>R</given-names>
</name>
<name>
<surname>Brabant</surname> <given-names>M</given-names>
</name>
<name>
<surname>Langonn&#xe9;</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidase</article-title>. <source>Cell Death Dis</source>. (<year>2012</year>) <volume>3</volume>:<fpage>e282</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cddis.2012.21</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fields</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Serger</surname> <given-names>E</given-names>
</name>
<name>
<surname>Campos</surname> <given-names>S</given-names>
</name>
<name>
<surname>Divakaruni</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>C</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders</article-title>. <source>Neurobiol Dis</source>. (<year>2016</year>) <volume>86</volume>:<page-range>154&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.nbd.2015.11.015</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vilhardt</surname> <given-names>F</given-names>
</name>
<name>
<surname>Plastre</surname> <given-names>O</given-names>
</name>
<name>
<surname>Sawada</surname> <given-names>M</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wiznerowicz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kiyokawa</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>The HIV-1 Nef protein and phagocyte NADPH oxidase activation</article-title>. <source>J Biol Chem</source>. (<year>2002</year>) <volume>277</volume>:<page-range>42136&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M200862200</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halestrap</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Brenner</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death</article-title>. <source>Curr Med Chem</source>. (<year>2003</year>) <volume>10</volume>:<page-range>1507&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/0929867033457278</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Flores</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Terada</surname> <given-names>LS</given-names>
</name>
</person-group>. <article-title>HIV Tat activates c-Jun amino-terminal kinase through an oxidant-dependent mechanism</article-title>. <source>Virology</source>. (<year>2001</year>) <volume>286</volume>:<fpage>62</fpage>&#x2013;<lpage>71</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/viro.2001.0998</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capone</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cervelli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Angelucci</surname> <given-names>E</given-names>
</name>
<name>
<surname>Colasanti</surname> <given-names>M</given-names>
</name>
<name>
<surname>Macone</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mariottini</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity</article-title>. <source>Free Radic Biol Med</source>. (<year>2013</year>) <volume>63</volume>:<fpage>99</fpage>&#x2013;<lpage>107</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.05.007</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozzi</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Borelli</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ryan</surname> <given-names>K</given-names>
</name>
<name>
<surname>Steiner</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Reglodi</surname> <given-names>D</given-names>
</name>
<name>
<surname>Mocchetti</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>PACAP27 is protective against tat-induced neurotoxicity</article-title>. <source>J Mol Neurosci</source>. (<year>2014</year>) <volume>54</volume>:<page-range>485&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12031-014-0273-z</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haughey</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Mattson</surname> <given-names>MP</given-names>
</name>
</person-group>. <article-title>Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120</article-title>. <source>J Acquir Immune Defic Syndr</source>. (<year>2002</year>) <volume>31 Suppl 2</volume>:<page-range>S55&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00126334-200210012-00005</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferri</surname> <given-names>KF</given-names>
</name>
<name>
<surname>Jacotot</surname> <given-names>E</given-names>
</name>
<name>
<surname>Blanco</surname> <given-names>J</given-names>
</name>
<name>
<surname>Est&#xe9;</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Kroemer</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Mitochondrial control of cell death induced by HIV-1-encoded proteins</article-title>. <source>Ann N Y Acad Sci</source>. (<year>2000</year>) <volume>926</volume>:<page-range>149&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1749-6632.2000.tb05609.x</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avdoshina</surname> <given-names>V</given-names>
</name>
<name>
<surname>Fields</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Castellano</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dedoni</surname> <given-names>S</given-names>
</name>
<name>
<surname>Palchik</surname> <given-names>G</given-names>
</name>
<name>
<surname>Trejo</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The HIV protein gp120 alters mitochondrial dynamics in neurons</article-title>. <source>Neurotox Res</source>. (<year>2016</year>) <volume>29</volume>:<page-range>583&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12640-016-9608-6</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elbim</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pillet</surname> <given-names>S</given-names>
</name>
<name>
<surname>Prevost</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Preira</surname> <given-names>A</given-names>
</name>
<name>
<surname>Girard</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Rogine</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>The role of phagocytes in HIV-related oxidative stress</article-title>. <source>J Clin Virol</source>. (<year>2001</year>) <volume>20</volume>:<fpage>99</fpage>&#x2013;<lpage>109</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1386-6532(00)00133-5</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elbim</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pillet</surname> <given-names>S</given-names>
</name>
<name>
<surname>Prevost</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Preira</surname> <given-names>A</given-names>
</name>
<name>
<surname>Girard</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Rogine</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load</article-title>. <source>J Virol</source>. (<year>1999</year>) <volume>73</volume>:<page-range>4561&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.73.6.4561-4566.1999</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burnstock</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>P2X ion channel receptors and inflammation</article-title>. <source>Purinergic Signal</source>. (<year>2016</year>) <volume>12</volume>:<fpage>59</fpage>&#x2013;<lpage>67</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11302-015-9493-0</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kopp</surname> <given-names>R</given-names>
</name>
<name>
<surname>Krautloher</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ram&#xed;rez-Fern&#xe1;ndez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nicke</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>P2X7 interactions and signaling - making head or tail of it</article-title>. <source>Front Mol Neurosci</source>. (<year>2019</year>) <volume>12</volume>:<elocation-id>183</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnmol.2019.00183</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Virgilio</surname> <given-names>F</given-names>
</name>
<name>
<surname>Schmalzing</surname> <given-names>G</given-names>
</name>
<name>
<surname>Markwardt</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>The elusive P2X7 macropore</article-title>. <source>Trends Cell Biol</source>. (<year>2018</year>) <volume>28</volume>:<fpage>392</fpage>&#x2013;<lpage>404</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tcb.2018.01.005</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pacheco</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Faria</surname> <given-names>RX</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>LG</given-names>
</name>
<name>
<surname>Paix&#xe3;o</surname> <given-names>IC</given-names>
</name>
</person-group>. <article-title>Putative roles of purinergic signaling in human immunodeficiency virus-1 infection</article-title>. <source>Biol Direct</source>. (<year>2014</year>) <volume>9</volume>:<fpage>21</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1745-6150-9-21</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubey</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Mishra</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gaur</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>G protein-coupled and ATP-sensitive inwardly rectifying potassium ion channels are essential for HIV entry</article-title>. <source>Sci Rep</source>. (<year>2019</year>) <volume>9</volume>:<fpage>4113</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-40968-x</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikolova</surname> <given-names>M</given-names>
</name>
<name>
<surname>Carriere</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jenabian</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Limou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Younas</surname> <given-names>M</given-names>
</name>
<name>
<surname>K&#xf6;k</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>CD39/adenosine pathway is involved in AIDS progression</article-title>. <source>PloS Pathog</source>. (<year>2011</year>) <volume>7</volume>:<fpage>e1002110</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1002110</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goepfert</surname> <given-names>C</given-names>
</name>
<name>
<surname>Imai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Brouard</surname> <given-names>S</given-names>
</name>
<name>
<surname>Csizmadia</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kaczmarek</surname> <given-names>E</given-names>
</name>
<name>
<surname>Robson</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>CD39 modulates endothelial cell activation and apoptosis</article-title>. <source>Mol Med</source>. (<year>2000</year>) <volume>6</volume>:<fpage>591</fpage>&#x2013;<lpage>603</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/BF03401797</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savio</surname> <given-names>LEB</given-names>
</name>
<name>
<surname>de Andrade Mello</surname> <given-names>P</given-names>
</name>
<name>
<surname>Figliuolo</surname> <given-names>VR</given-names>
</name>
<name>
<surname>de Avelar Almeida</surname> <given-names>TF</given-names>
</name>
<name>
<surname>Santana</surname> <given-names>PT</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>SDS</given-names>
</name>
<etal/>
</person-group>. <article-title>CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury</article-title>. <source>J Hepatol</source>. (<year>2017</year>) <volume>67</volume>:<page-range>716&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jhep.2017.05.021</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soare</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Malik</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Durham</surname> <given-names>ND</given-names>
</name>
<name>
<surname>Freeman</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>R</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>P2X1 selective antagonists block HIV-1 infection through inhibition of envelope conformation-dependent fusion</article-title>. <source>J Virol</source>. (<year>2020</year>) <volume>94</volume>(<issue>6</issue>)<fpage>:e01622&#x2013;19</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.01622-19</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>S&#xe9;ror</surname> <given-names>C</given-names>
</name>
<name>
<surname>Melki</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Subra</surname> <given-names>F</given-names>
</name>
<name>
<surname>Raza</surname> <given-names>SQ</given-names>
</name>
<name>
<surname>Bras</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sa&#xef;di</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection</article-title>. <source>J Exp Med</source>. (<year>2011</year>) <volume>208</volume>:<page-range>1823&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20101805</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soare</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Durham</surname> <given-names>ND</given-names>
</name>
<name>
<surname>Gopal</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tweel</surname> <given-names>B</given-names>
</name>
<name>
<surname>Hoffman</surname> <given-names>KW</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>JA</given-names>
</name>
<etal/>
</person-group>. <article-title>P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines interleukin-10 (IL-10) and IL-1&#x3b2; in a human tonsil explant model</article-title>. <source>J Virol</source>. (<year>2019</year>) <volume>93</volume>:<page-range>e01186&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.01186-18</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swartz</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Dubyak</surname> <given-names>GR</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>BK</given-names>
</name>
</person-group>. <article-title>Purinergic receptors: key mediators of HIV-1 infection and inflammation</article-title>. <source>Front Immunol</source>. (<year>2015</year>) <volume>6</volume>:<elocation-id>585</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2015.00585</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giroud</surname> <given-names>C</given-names>
</name>
<name>
<surname>Marin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hammonds</surname> <given-names>J</given-names>
</name>
<name>
<surname>Spearman</surname> <given-names>P</given-names>
</name>
<name>
<surname>Melikyan</surname> <given-names>GB</given-names>
</name>
</person-group>. <article-title>P2X1 receptor antagonists inhibit HIV-1 fusion by blocking virus-coreceptor interactions</article-title>. <source>J Virol</source>. (<year>2015</year>) <volume>89</volume>:<page-range>9368&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.01178-15</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Du</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Giroud</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Qui</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>High-throughput HIV-cell fusion assay for discovery of virus entry inhibitors</article-title>. <source>Assay Drug Dev Technol</source>. (<year>2015</year>) <volume>13</volume>:<page-range>155&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/adt.2015.639</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swartz</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Esposito</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Durham</surname> <given-names>ND</given-names>
</name>
<name>
<surname>Hartmann</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>BK</given-names>
</name>
</person-group>. <article-title>P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection</article-title>. <source>J Virol</source>. (<year>2014</year>) <volume>88</volume>:<page-range>11504&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.01158-14</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hazleton</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Berman</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Eugenin</surname> <given-names>EA</given-names>
</name>
</person-group>. <article-title>Purinergic receptors are required for HIV-1 infection of primary human macrophages</article-title>. <source>J Immunol</source>. (<year>2012</year>) <volume>188</volume>:<page-range>4488&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1102482</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soare</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Freeman</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Min</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Malik</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Osota</surname> <given-names>EO</given-names>
</name>
<name>
<surname>Swartz</surname> <given-names>TH</given-names>
</name>
</person-group>. <article-title>P2RX7 at the host-pathogen interface of infectious diseases</article-title>. <source>Microbiol Mol Biol Rev</source>. (<year>2021</year>) <volume>85</volume>(<issue>1</issue>)<fpage>:e00055&#x2013;20</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MMBR.00055-20</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Soare</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>F</given-names>
</name>
<name>
<surname>Satija</surname> <given-names>N</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>BK</given-names>
</name>
<name>
<surname>Swartz</surname> <given-names>TH</given-names>
</name>
</person-group>. <article-title>A high-throughput cre-lox activated viral membrane fusion assay to identify inhibitors of HIV-1 viral membrane fusion</article-title>. <source>J Vis Exp</source>. (<year>2018</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.3791/58074-v</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>P</given-names>
</name>
<name>
<surname>Swartz</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tsibane</surname> <given-names>T</given-names>
</name>
<name>
<surname>Durham</surname> <given-names>ND</given-names>
</name>
<etal/>
</person-group>. <article-title>A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry</article-title>. <source>Virology</source>. (<year>2016</year>) <volume>490</volume>:<fpage>6</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.virol.2015.10.013</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunt</surname> <given-names>PW</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Sinclair</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bredt</surname> <given-names>B</given-names>
</name>
<name>
<surname>Hagos</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lampiris</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy</article-title>. <source>J Infect Dis</source>. (<year>2003</year>) <volume>187</volume>:<page-range>1534&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/374786</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massanella</surname> <given-names>M</given-names>
</name>
<name>
<surname>Negredo</surname> <given-names>E</given-names>
</name>
<name>
<surname>Perez-Alvarez</surname> <given-names>N</given-names>
</name>
<name>
<surname>Puig</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ruiz-Hernandez</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bofill</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART</article-title>. <source>AIDS</source>. (<year>2010</year>) <volume>24</volume>:<page-range>959&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/QAD.0b013e328337b957</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massanella</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fromentin</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chomont</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Residual inflammation and viral reservoirs: alliance against an HIV cure</article-title>. <source>Curr Opin HIV AIDS</source>. (<year>2016</year>) <volume>11</volume>:<page-range>234&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/COH.0000000000000230</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iyer</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Pulskens</surname> <given-names>WP</given-names>
</name>
<name>
<surname>Sadler</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Butter</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Teske</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Ulland</surname> <given-names>TK</given-names>
</name>
<etal/>
</person-group>. <article-title>Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2009</year>) <volume>106</volume>:<page-range>20388&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0908698106</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariathasan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Newton</surname> <given-names>K</given-names>
</name>
<name>
<surname>McBride</surname> <given-names>J</given-names>
</name>
<name>
<surname>O&#x2019;Rourke</surname> <given-names>K</given-names>
</name>
<name>
<surname>Roose-Girma</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Cryopyrin activates the inflammasome in response to toxins and ATP</article-title>. <source>Nature</source>. (<year>2006</year>) <volume>440</volume>:<page-range>228&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature04515</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hung</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Said-Sadier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>L</given-names>
</name>
<name>
<surname>Atanasova</surname> <given-names>KR</given-names>
</name>
<name>
<surname>Sellami</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>P2X4 assembles with P2X7 and pannexin-1 in gingival epithelial cells and modulates ATP-induced reactive oxygen species production and inflammasome activation</article-title>. <source>PloS One</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e70210</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0070210</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>W</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome</article-title>. <source>Cell Death Dis</source>. (<year>2019</year>) <volume>10</volume>:<fpage>542</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-019-1761-4</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malik</surname> <given-names>S</given-names>
</name>
<name>
<surname>Eugenin</surname> <given-names>EA</given-names>
</name>
</person-group>. <article-title>Role of Connexin and Pannexin containing channels in HIV infection and NeuroAIDS</article-title>. <source>Neurosci Lett</source>. (<year>2019</year>) <volume>695</volume>:<fpage>86</fpage>&#x2013;<lpage>90</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.neulet.2017.09.005</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orellana</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Velasquez</surname> <given-names>S</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>DW</given-names>
</name>
<name>
<surname>S&#xe1;ez</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Berman</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Eugenin</surname> <given-names>EA</given-names>
</name>
</person-group>. <article-title>Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes</article-title>. <source>J Leukoc Biol</source>. (<year>2013</year>) <volume>94</volume>:<fpage>399</fpage>&#x2013;<lpage>407</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.0512249</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gajardo-G&#xf3;mez</surname> <given-names>R</given-names>
</name>
<name>
<surname>Santiba&#xf1;ez</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Labra</surname> <given-names>VC</given-names>
</name>
<name>
<surname>G&#xf3;mez</surname> <given-names>GI</given-names>
</name>
<name>
<surname>Eugenin</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Orellana</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>HIV gp120 protein increases the function of connexin 43 hemichannels and pannexin-1 channels in astrocytes: repercussions on astroglial function</article-title>. <source>Int J Mol Sci</source>. (<year>2020</year>) <volume>21</volume>(<issue>7</issue>)<fpage>:2503</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21072503</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freeman</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Schrode</surname> <given-names>N</given-names>
</name>
<name>
<surname>Fortune</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shroff</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tweel</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>HIV-1 activates oxidative phosphorylation in infected CD4 T cells in a human tonsil explant model</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1172938</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1172938</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velasquez</surname> <given-names>S</given-names>
</name>
<name>
<surname>Prevedel</surname> <given-names>L</given-names>
</name>
<name>
<surname>Valdebenito</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gorska</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Golovko</surname> <given-names>M</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Circulating levels of ATP is a biomarker of HIV cognitive impairment</article-title>. <source>EBioMedicine</source>. (<year>2020</year>) <volume>51</volume>:<fpage>102503</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ebiom.2019.10.029</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heaton</surname> <given-names>RK</given-names>
</name>
<name>
<surname>Clifford</surname> <given-names>DB</given-names>
</name>
<name>
<surname>Franklin</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Woods</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Ake</surname> <given-names>C</given-names>
</name>
<name>
<surname>Vaida</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study</article-title>. <source>Neurology</source>. (<year>2010</year>) <volume>75</volume>:<page-range>2087&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1212/WNL.0b013e318200d727</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zayyad</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Spudich</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND)</article-title>. <source>Curr HIV/AIDS Rep</source>. (<year>2015</year>) <volume>12</volume>:<fpage>16</fpage>&#x2013;<lpage>24</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11904-014-0255-3</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veenstra</surname> <given-names>M</given-names>
</name>
<name>
<surname>Le&#xf3;n-Rivera</surname> <given-names>R</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gama</surname> <given-names>L</given-names>
</name>
<name>
<surname>Clements</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Berman</surname> <given-names>JW</given-names>
</name>
</person-group>. <article-title>Mechanisms of CNS viral seeding by HIV</article-title>. <source>mBio</source>. (<year>2017</year>) <volume>8</volume>(<issue>5</issue>)<fpage>:e01280&#x2013;17</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.01280-17</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Datta</surname> <given-names>G</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Afghah</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Geiger</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>HIV-1 gp120 promotes lysosomal exocytosis in human schwann cells</article-title>. <source>Front Cell Neurosci</source>. (<year>2019</year>) <volume>13</volume>:<elocation-id>329</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fncel.2019.00329</pub-id>
</citation>
</ref>
<ref id="B102">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ugawa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ueda</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ishida</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Inoue</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kyaw Nyunt</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Cellular localization of P2X7 receptor mRNA in the rat brain</article-title>. <source>Brain Res</source>. (<year>2008</year>) <volume>1194</volume>:<fpage>45</fpage>&#x2013;<lpage>55</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.brainres.2007.11.064</pub-id>
</citation>
</ref>
<ref id="B103">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kakuda</surname> <given-names>TN</given-names>
</name>
</person-group>. <article-title>Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity</article-title>. <source>Clin Ther</source>. (<year>2000</year>) <volume>22</volume>:<fpage>685</fpage>&#x2013;<lpage>708</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0149-2918(00)90004-3</pub-id>
</citation>
</ref>
<ref id="B104">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname> <given-names>K</given-names>
</name>
<name>
<surname>Liner</surname> <given-names>J</given-names>
</name>
<name>
<surname>Meeker</surname> <given-names>RB</given-names>
</name>
</person-group>. <article-title>Antiretroviral neurotoxicity</article-title>. <source>J Neurovirol</source>. (<year>2012</year>) <volume>18</volume>:<page-range>388&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s13365-012-0120-3</pub-id>
</citation>
</ref>
<ref id="B105">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheney</surname> <given-names>L</given-names>
</name>
<name>
<surname>Guzik</surname> <given-names>H</given-names>
</name>
<name>
<surname>Macaluso</surname> <given-names>FP</given-names>
</name>
<name>
<surname>Macian</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cuervo</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Berman</surname> <given-names>JW</given-names>
</name>
</person-group>. <article-title>HIV Nef and antiretroviral therapy have an inhibitory effect on autophagy in human astrocytes that may contribute to HIV-associated neurocognitive disorders</article-title>. <source>Cells</source>. (<year>2020</year>) <volume>9</volume>(<issue>6</issue>)<fpage>:1426</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells9061426</pub-id>
</citation>
</ref>
<ref id="B106">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Ghneim</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Rampanelli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Holley-Guthrie</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Multi-omics analyses reveal that HIV-1 alters CD4</article-title>. <source>Nat Immunol</source>. (<year>2021</year>) <volume>22</volume>:<page-range>423&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-021-00898-1</pub-id>
</citation>
</ref>
<ref id="B107">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ambikan</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Svensson-Akusj&#xe4;rvi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Krishnan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sperk</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nowak</surname> <given-names>P</given-names>
</name>
<name>
<surname>Vesterbacka</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection</article-title>. <source>Life Sci Alliance</source>. (<year>2022</year>) <volume>5</volume>(<issue>9</issue>)<fpage>:e202201405</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.26508/lsa.202201405</pub-id>
</citation>
</ref>
<ref id="B108">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alrubayyi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Moreno-Cubero</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hameiri-Bowen</surname> <given-names>D</given-names>
</name>
<name>
<surname>Matthews</surname> <given-names>R</given-names>
</name>
<name>
<surname>Rowland-Jones</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schurich</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional restoration of exhausted CD8 T cells in chronic HIV-1 infection by targeting mitochondrial dysfunction</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>908697</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.908697</pub-id>
</citation>
</ref>
<ref id="B109">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castellano</surname> <given-names>P</given-names>
</name>
<name>
<surname>Prevedel</surname> <given-names>L</given-names>
</name>
<name>
<surname>Valdebenito</surname> <given-names>S</given-names>
</name>
<name>
<surname>Eugenin</surname> <given-names>EA</given-names>
</name>
</person-group>. <article-title>HIV infection and latency induce a unique metabolic signature in human macrophages</article-title>. <source>Sci Rep</source>. (<year>2019</year>) <volume>9</volume>:<fpage>3941</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-39898-5</pub-id>
</citation>
</ref>
<ref id="B110">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aquaro</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cali&#xf2;</surname> <given-names>R</given-names>
</name>
<name>
<surname>Balzarini</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bellocchi</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Garaci</surname> <given-names>E</given-names>
</name>
<name>
<surname>Perno</surname> <given-names>CF</given-names>
</name>
</person-group>. <article-title>Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir</article-title>. <source>Antiviral Res</source>. (<year>2002</year>) <volume>55</volume>:<page-range>209&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0166-3542(02)00052-9</pub-id>
</citation>
</ref>
<ref id="B111">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezaei</surname> <given-names>S</given-names>
</name>
<name>
<surname>Timani</surname> <given-names>KA</given-names>
</name>
<name>
<surname>He</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Metformin treatment leads to increased HIV transcription and gene expression through increased CREB phosphorylation and recruitment to the HIV LTR promoter</article-title>. <source>Aging Dis</source>. (<year>2023</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.14336/AD.2023.0705</pub-id>
</citation>
</ref>
<ref id="B112">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortiz-Brizuela</surname> <given-names>E</given-names>
</name>
<name>
<surname>P&#xe9;rez-Patrigeon</surname> <given-names>S</given-names>
</name>
<name>
<surname>Recillas-Gispert</surname> <given-names>C</given-names>
</name>
<name>
<surname>G&#xf3;mez-P&#xe9;rez</surname> <given-names>FJ</given-names>
</name>
</person-group>. <article-title>Lactic acidosis complicating metformin and non-nucleoside reverse transcriptase inhibitor combination therapy: A smoldering threat in the post-HAART era</article-title>. <source>Rev Invest Clin</source>. (<year>2015</year>) <volume>67</volume>:<page-range>273&#x2013;4</page-range>.</citation>
</ref>
<ref id="B113">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaparala</surname> <given-names>S</given-names>
</name>
<name>
<surname>Da Silva</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Papadopoulos</surname> <given-names>JP</given-names>
</name>
</person-group>. <article-title>Severe lactic acidosis due to acute intoxication by emtricitabine/tenofovir alafenamide</article-title>. <source>Cureus</source>. (<year>2021</year>) <volume>13</volume>:<fpage>e19008</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7759/cureus.19008</pub-id>
</citation>
</ref>
<ref id="B114">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adebiyi</surname> <given-names>OO</given-names>
</name>
<name>
<surname>Adebiyi</surname> <given-names>OA</given-names>
</name>
<name>
<surname>Owira</surname> <given-names>PM</given-names>
</name>
</person-group>. <article-title>Naringin reverses hepatocyte apoptosis and oxidative stress associated with HIV-1 nucleotide reverse transcriptase inhibitors-induced metabolic complications</article-title>. <source>Nutrients</source>. (<year>2015</year>) <volume>7</volume>:<page-range>10352&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu7125540</pub-id>
</citation>
</ref>
<ref id="B115">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oluwafeyisetan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Olubunmi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Peter</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Naringin ameliorates HIV-1 nucleoside reverse transcriptase inhibitors- induced mitochondrial toxicity</article-title>. <source>Curr HIV Res</source>. (<year>2016</year>) <volume>14</volume>:<page-range>506&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1570162X14666160520114639</pub-id>
</citation>
</ref>
<ref id="B116">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Funderburg</surname> <given-names>NT</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Debanne</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Labbato</surname> <given-names>D</given-names>
</name>
<name>
<surname>Juchnowski</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ferrari</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy</article-title>. <source>J Acquir Immune Defic Syndr</source>. (<year>2015</year>) <volume>68</volume>:<fpage>396</fpage>&#x2013;<lpage>404</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/QAI.0000000000000478</pub-id>
</citation>
</ref>
<ref id="B117">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grinspoon</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Fitch</surname> <given-names>KV</given-names>
</name>
<name>
<surname>Zanni</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Fichtenbaum</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Umbleja</surname> <given-names>T</given-names>
</name>
<name>
<surname>Aberg</surname> <given-names>JA</given-names>
</name>
<etal/>
</person-group>. <article-title>Pitavastatin to prevent cardiovascular disease in HIV infection</article-title>. <source>N Engl J Med</source>. (<year>2023</year>) <volume>389</volume>:<page-range>687&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMoa2304146</pub-id>
</citation>
</ref>
<ref id="B118">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Longenecker</surname> <given-names>CT</given-names>
</name>
<name>
<surname>Mittelsteadt</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Debanne</surname> <given-names>SM</given-names>
</name>
<name>
<surname>McComsey</surname> <given-names>GA</given-names>
</name>
</person-group>. <article-title>Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy</article-title>. <source>HIV Clin Trials</source>. (<year>2016</year>) <volume>17</volume>:<page-range>140&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15284336.2016.1184863</pub-id>
</citation>
</ref>
<ref id="B119">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>HIV-1 infection and glucose metabolism reprogramming of T cells: another approach toward functional cure and reservoir eradication</article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>572677</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.572677</pub-id>
</citation>
</ref>
<ref id="B120">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname> <given-names>CNS</given-names>
</name>
<name>
<surname>Arjona</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Santerre</surname> <given-names>M</given-names>
</name>
<name>
<surname>De Lucia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Koch</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Sawaya</surname> <given-names>BE</given-names>
</name>
</person-group>. <article-title>Metabolic reprogramming in HIV-associated neurocognitive disorders</article-title>. <source>Front Cell Neurosci</source>. (<year>2022</year>) <volume>16</volume>:<elocation-id>812887</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fncel.2022.812887</pub-id>
</citation>
</ref>
<ref id="B121">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parikh</surname> <given-names>NI</given-names>
</name>
<name>
<surname>Gerschenson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bennett</surname> <given-names>K</given-names>
</name>
<name>
<surname>Gangcuangco</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Lopez</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Mehta</surname> <given-names>NN</given-names>
</name>
<etal/>
</person-group>. <article-title>Lipoprotein concentration, particle number, size and cholesterol efflux capacity are associated with mitochondrial oxidative stress and function in an HIV positive cohort</article-title>. <source>Atherosclerosis</source>. (<year>2015</year>) <volume>239</volume>:<page-range>50&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2014.12.005</pub-id>
</citation>
</ref>
<ref id="B122">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perrin</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cremer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Roll</surname> <given-names>P</given-names>
</name>
<name>
<surname>Faucher</surname> <given-names>O</given-names>
</name>
<name>
<surname>M&#xe9;nard</surname> <given-names>A</given-names>
</name>
<name>
<surname>Reynes</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 &#x201c;Aging&#x201d;</article-title>. <source>Study PloS One</source>. (<year>2012</year>) <volume>7</volume>:<fpage>e41129</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0041129</pub-id>
</citation>
</ref>
<ref id="B123">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Lewis</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Aging and HIV/AIDS: pathogenetic role of therapeutic side effects</article-title>. <source>Lab Invest</source>. (<year>2014</year>) <volume>94</volume>:<page-range>120&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/labinvest.2013.142</pub-id>
</citation>
</ref>
<ref id="B124">
<label>124</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arts</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Hazuda</surname> <given-names>DJ</given-names>
</name>
</person-group>. <article-title>HIV-1 antiretroviral drug therapy</article-title>. <source>Cold Spring Harb Perspect Med</source>. (<year>2012</year>) <volume>2</volume>:<fpage>a007161</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/cshperspect.a007161</pub-id>
</citation>
</ref>
<ref id="B125">
<label>125</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mir&#xf3;</surname> <given-names>O</given-names>
</name>
<name>
<surname>L&#xf3;pez</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Pedrol</surname> <given-names>E</given-names>
</name>
<name>
<surname>Milinkovic</surname> <given-names>A</given-names>
</name>
<name>
<surname>Deig</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals</article-title>. <source>Clin Infect Dis</source>. (<year>2004</year>) <volume>39</volume>:<page-range>710&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/423176</pub-id>
</citation>
</ref>
<ref id="B126">
<label>126</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brinkman</surname> <given-names>K</given-names>
</name>
<name>
<surname>ter Hofstede</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Burger</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Smeitink</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Koopmans</surname> <given-names>PP</given-names>
</name>
</person-group>. <article-title>Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway</article-title>. <source>AIDS</source>. (<year>1998</year>) <volume>12</volume>:<page-range>1735&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00002030-199814000-00004</pub-id>
</citation>
</ref>
<ref id="B127">
<label>127</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Apostolova</surname> <given-names>N</given-names>
</name>
<name>
<surname>Blas-Garc&#xed;a</surname> <given-names>A</given-names>
</name>
<name>
<surname>Esplugues</surname> <given-names>JV</given-names>
</name>
</person-group>. <article-title>Mitochondrial toxicity in HAART: an overview of in <italic>vitro</italic> evidence</article-title>. <source>Curr Pharm Des</source>. (<year>2011</year>) <volume>17</volume>:<page-range>2130&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/138161211796904731</pub-id>
</citation>
</ref>
<ref id="B128">
<label>128</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiala</surname> <given-names>M</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>T</given-names>
</name>
<name>
<surname>MacDougall</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Luque</surname> <given-names>A</given-names>
</name>
<name>
<surname>Iruela-Arispe</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>HAART drugs induce mitochondrial damage and intercellular gaps and gp120 causes apoptosis</article-title>. <source>Cardiovasc Toxicol</source>. (<year>2004</year>) <volume>4</volume>:<page-range>327&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1385/CT:4:4</pub-id>
</citation>
</ref>
<ref id="B129">
<label>129</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaur</surname> <given-names>H</given-names>
</name>
<name>
<surname>Minchella</surname> <given-names>P</given-names>
</name>
<name>
<surname>Alvarez-Carbonell</surname> <given-names>D</given-names>
</name>
<name>
<surname>Purandare</surname> <given-names>N</given-names>
</name>
<name>
<surname>Nagampalli</surname> <given-names>VK</given-names>
</name>
<name>
<surname>Blankenberg</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Contemporary antiretroviral therapy dysregulates iron transport and augments mitochondrial dysfunction in HIV-infected human microglia and neural-lineage cells</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>(<issue>15</issue>)<fpage>:12242</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.20944/preprints202307.1492.v1</pub-id>
</citation>
</ref>
<ref id="B130">
<label>130</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>H</given-names>
</name>
<name>
<surname>Rajan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Narasipura</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Virdi</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Olali</surname> <given-names>AZ</given-names>
</name>
<etal/>
</person-group>. <article-title>Anti-HIV drugs cause mitochondrial dysfunction in monocyte-derived macrophages</article-title>. <source>Antimicrob Agents Chemother</source>. (<year>2022</year>) <volume>66</volume>:<fpage>e0194121</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aac.01941-21</pub-id>
</citation>
</ref>
<ref id="B131">
<label>131</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xf3;pez</surname> <given-names>S</given-names>
</name>
<name>
<surname>Negredo</surname> <given-names>E</given-names>
</name>
<name>
<surname>Garrabou</surname> <given-names>G</given-names>
</name>
<name>
<surname>Puig</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ruiz</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sanjurjo</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Longitudinal study on mitochondrial effects of didanosine-tenofovir combination</article-title>. <source>AIDS Res Hum Retroviruses</source>. (<year>2006</year>) <volume>22</volume>:<page-range>33&#x2013;9</page-range>.
doi:&#xa0;<pub-id pub-id-type="doi">10.1089/aid.2006.22.33</pub-id></citation></ref>
<ref id="B132">
<label>132</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massanella</surname> <given-names>M</given-names>
</name>
<name>
<surname>Singhania</surname> <given-names>A</given-names>
</name>
<name>
<surname>Beliakova-Bethell</surname> <given-names>N</given-names>
</name>
<name>
<surname>Pier</surname> <given-names>R</given-names>
</name>
<name>
<surname>Lada</surname> <given-names>SM</given-names>
</name>
<name>
<surname>White</surname> <given-names>CH</given-names>
</name>
<etal/>
</person-group>. <article-title>Differential gene expression in HIV-infected individuals following ART</article-title>. <source>Antiviral Res</source>. (<year>2013</year>) <volume>100</volume>:<page-range>420&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.antiviral.2013.07.017</pub-id>
</citation>
</ref>
<ref id="B133">
<label>133</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gangcuangco</surname> <given-names>LMA</given-names>
</name>
<name>
<surname>Mitchell</surname> <given-names>BI</given-names>
</name>
<name>
<surname>Siriwardhana</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kohorn</surname> <given-names>LB</given-names>
</name>
<name>
<surname>Chew</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Bowler</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial oxidative phosphorylation in peripheral blood mononuclear cells is decreased in chronic HIV and correlates with immune dysregulation</article-title>. <source>PloS One</source>. (<year>2020</year>) <volume>15</volume>:<fpage>e0231761</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0231761</pub-id>
</citation>
</ref>
<ref id="B134">
<label>134</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowman</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Cameron</surname> <given-names>C</given-names>
</name>
<name>
<surname>Richardson</surname> <given-names>B</given-names>
</name>
<name>
<surname>Kulkarni</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gabriel</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kettelhut</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Exposure of leukocytes to HIV preexposure prophylaxis decreases mitochondrial function and alters gene expression profiles</article-title>. <source>Antimicrob Agents Chemother</source>. (<year>2020</year>) <volume>65</volume>(<issue>1</issue>)<fpage>:e01755&#x2013;20</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.01755-20</pub-id>
</citation>
</ref>
<ref id="B135">
<label>135</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butterfield</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Landay</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Anzinger</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Dysfunctional immunometabolism in HIV infection: contributing factors and implications for age-related comorbid diseases</article-title>. <source>Curr HIV/AIDS Rep</source>. (<year>2020</year>) <volume>17</volume>:<page-range>125&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11904-020-00484-4</pub-id>
</citation>
</ref>
<ref id="B136">
<label>136</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schank</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Moorman</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>ZQ</given-names>
</name>
</person-group>. <article-title>The impact of HIV- and ART-induced mitochondrial dysfunction in cellular senescence and aging</article-title>. <source>Cells</source>. (<year>2021</year>) <volume>10</volume>(<issue>1</issue>)<fpage>:174</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells10010174</pub-id>
</citation>
</ref>
<ref id="B137">
<label>137</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Guilbaud</surname> <given-names>E</given-names>
</name>
<name>
<surname>Tait</surname> <given-names>SWG</given-names>
</name>
<name>
<surname>Yamazaki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Galluzzi</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Mitochondrial control of inflammation</article-title>. <source>Nat Rev Immunol</source>. (<year>2023</year>) <volume>23</volume>:<page-range>159&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577-022-00760-x</pub-id>
</citation>
</ref>
<ref id="B138">
<label>138</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Label-free proteomic analysis of PBMCs reveals gender differences in response to long-term antiretroviral therapy of HIV</article-title>. <source>J Proteomics</source>. (<year>2015</year>) <volume>126</volume>:<fpage>46</fpage>&#x2013;<lpage>53</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jprot.2015.05.033</pub-id>
</citation>
</ref>
<ref id="B139">
<label>139</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravimohan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tamuhla</surname> <given-names>N</given-names>
</name>
<name>
<surname>Nfanyana</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ni</surname> <given-names>H</given-names>
</name>
<name>
<surname>Steenhoff</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Gross</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated pre-antiretroviral therapy CD39+CD8+ T cell frequency is associated with early mortality in advanced human immunodeficiency virus/tuberculosis co-infection</article-title>. <source>Clin Infect Dis</source>. (<year>2017</year>) <volume>64</volume>:<page-range>1453&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cid/cix155</pub-id>
</citation>
</ref>
<ref id="B140">
<label>140</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahbaz</surname> <given-names>S</given-names>
</name>
<name>
<surname>Okoye</surname> <given-names>I</given-names>
</name>
<name>
<surname>Blevins</surname> <given-names>G</given-names>
</name>
<name>
<surname>Elahi</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals</article-title>. <source>PloS Pathog</source>. (<year>2022</year>) <volume>18</volume>:<fpage>e1010378</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1010378</pub-id>
</citation>
</ref>
<ref id="B141">
<label>141</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>HH</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>RN</given-names>
</name>
<etal/>
</person-group>. <article-title>Expression of CD39 is correlated with HIV DNA levels in na&#xef;ve tregs in chronically infected ART na&#xef;ve patients</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>2465</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.02465</pub-id>
</citation>
</ref>
<ref id="B142">
<label>142</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadenbach</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Intrinsic and extrinsic uncoupling of oxidative phosphorylation</article-title>. <source>Biochim Biophys Acta</source>. (<year>2003</year>) <volume>1604</volume>:<fpage>77</fpage>&#x2013;<lpage>94</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0005-2728(03)00027-6</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>